Study of GP681 Tablets Compared With Placebo in Patients With Influenza at High Risk of Influenza Complications
Clinical trial NCT06573008 · RECRUITING
Trial details
- NCT number
- NCT06573008
- Sponsor
- Jiangxi Qingfeng Pharmaceutical Co. Ltd.
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-11-11
- Primary completion
- 2025-12-30
- Enrollment
- 328
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.